Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis.

Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis.

Item
http://www.wikidata.org/entity/Q34635942
Inhibitory Effects of KP-A159, a Thiazolopyridine Derivative, on Osteoclast Differentiation, Function, and Inflammatory Bone Loss via Suppression of RANKL-Induced MAP Kinase Signaling PathwayThe Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblastsOral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities.Inhibition of osteoclast differentiation and bone resorption by N-methylpyrrolidoneAbsence of platelet-activating factor receptor protects mice from osteoporosis following ovariectomy.Effect of Fermented Red Ginseng Extract Enriched in Ginsenoside Rg3 on the Differentiation and Mineralization of Preosteoblastic MC3T3-E1 Cells.Stauntonia hexaphylla (Lardizabalaceae) leaf methanol extract inhibits osteoclastogenesis and bone resorption activity via proteasome-mediated degradation of c-Fos protein and suppression of NFATc1 expression.Dihydroartemisinin prevents breast cancer-induced osteolysis via inhibiting both breast caner cells and osteoclasts.The Simultaneous Inhibitory Effect of Niclosamide on RANKL-Induced Osteoclast Formation and Osteoblast DifferentiationNanotechnology Treatment Options for Osteoporosis and Its Corresponding Consequences.Andrographolide prevents human breast cancer-induced osteoclastic bone loss via attenuated RANKL signaling.Amorphigenin inhibits Osteoclast differentiation by suppressing c-Fos and nuclear factor of activated T cells.Pharmacokinetics of modified oral calcitonin product in healthy volunteers.Preparation and in vitro-in vivo evaluation of salmon calcitonin-loaded polymeric nanoparticles.Effects of calcitonin on orthodontic tooth movement and associated root resorption in rats.Inhibition of Osteoclast Differentiation by Ginsenoside Rg3 in RAW264.7 Cells via RANKL, JNK and p38 MAPK Pathways Through a Modulation of Cathepsin K: An In Silico and In Vitro Study.
P2860

Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis.

Item
http://www.wikidata.org/entity/Q34635942
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis.
@ast
Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis.
@en
Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis.
@nl
type
label
Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis.
@ast
Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis.
@en
Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis.
@nl
prefLabel
Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis.
@ast
Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis.
@en
Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis.
@en
P2093
P304
P31
P356
10.1016/S8756-3282(02)00715-9
P433
P478
P577
P698
P921